logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Mackaness, James Hugh
    Born in December 1963
    Individual (2 offsprings)
    Officer
    icon of calendar 2023-07-21 ~ now
    OF - Director → CIF 0
  • 2
    Bhatnagar, Anish, Dr
    Born in December 1967
    Individual (2 offsprings)
    Officer
    icon of calendar 2015-04-27 ~ now
    OF - Director → CIF 0
  • 3
    icon of addressSuite 400, 100 Marine Parkway, Redwood City, United States
    Corporate (1 offspring)
    Person with significant control
    icon of calendar 2017-07-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 2
  • 1
    Joseph Anthony, Rosanne Vivian
    Sales And Marketing Director born in July 1968
    Individual (5 offsprings)
    Officer
    icon of calendar 2015-04-27 ~ 2023-07-21
    OF - Director → CIF 0
  • 2
    O'toole, David
    Cheif Financial Officer born in December 1958
    Individual (1 offspring)
    Officer
    icon of calendar 2015-04-27 ~ 2017-10-20
    OF - Director → CIF 0
parent relation
Company in focus

SOLENO THERAPEUTICS UK LTD

Previous names
CAPNIA (UK) LIMITED - 2017-10-31
SOLENO GB LTD - 2023-01-27
SOLENO THERAPEUTICS UK LTD - 2022-12-14
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Debtors
1,144,401 USD2024-12-31
2,041,595 USD2023-12-31
Cash at bank and in hand
193,173 USD2024-12-31
Current Assets
1,337,574 USD2024-12-31
2,041,595 USD2023-12-31
Net Current Assets/Liabilities
323,818 USD2024-12-31
326,318 USD2023-12-31
Total Assets Less Current Liabilities
323,818 USD2024-12-31
326,318 USD2023-12-31
Equity
Called up share capital
152 USD2024-12-31
152 USD2023-12-31
Retained earnings (accumulated losses)
323,666 USD2024-12-31
326,166 USD2023-12-31
Equity
323,818 USD2024-12-31
326,318 USD2023-12-31
Amounts Owed by Group Undertakings
Current
1,137,983 USD2024-12-31
1,861,218 USD2023-12-31
Other Debtors
Amounts falling due within one year, Current
6,418 USD2024-12-31
180,377 USD2023-12-31
Debtors
Amounts falling due within one year, Current
1,144,401 USD2024-12-31
2,041,595 USD2023-12-31
Trade Creditors/Trade Payables
Current
77,623 USD2024-12-31
96,335 USD2023-12-31
Other Taxation & Social Security Payable
Current
943 USD2024-12-31
76,199 USD2023-12-31
Other Creditors
Current
935,190 USD2024-12-31
1,542,743 USD2023-12-31

  • SOLENO THERAPEUTICS UK LTD
    Info
    CAPNIA (UK) LIMITED - 2017-10-31
    SOLENO GB LTD - 2017-10-31
    SOLENO THERAPEUTICS UK LTD - 2017-10-31
    Registered number 09563670
    icon of addressSuite 4 7th Floor, 50 Broadway, London SW1H 0DB
    PRIVATE LIMITED COMPANY incorporated on 2015-04-27 (10 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-02
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.